A Phase III study of perioperative dostarlimab in patients with dMMR/MSI-H resectable colon cancer: AZUR-2 study design
一项针对伴有dMMR/MSI-H可切除结肠癌患者的围手术期多斯他利单抗III期研究:AZUR-2研究设计
期刊:Future Oncology
影响因子:2.6
doi:10.1080/14796694.2025.2606910
Starling, Naureen; Elez, Elena; Strickler, John H; Benson, Al; Oki, Eiji; Mendez, Guillermo; Ferreiro, Reyes; Lau, Yong Loo; Kawazoe, Akihito; Tian, Min; Campbell, Nicole; Cohen, Daniel N; Edwards, Ken; Stjepanovic, Neda; Seligmann, Jenny F